Research ExplorerResearch UnitsDepartment for Urology Publications

Department for Urology

1651 - 1700 out of 1,860Page size: 50

Publications

  1. 2008

  2. [Is rehabilitation of erectile function following pelvic surgery reasonable? Review of the literature: from sports to PDE5 inhibitors]

    Mathers, M. J., Klotz, T., Vahlensieck, W., Zellner, M., Lümmen, G., Roth, S., Huland, H. & Sommer, F., 2008, In: UROLOGE. 47, 6, p. 685-692 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Long-term treatment of erectile dysfunction with a phosphodiesterase-5 inhibitor and dose optimization based on nocturnal penile tumescence.

    Mathers, M. J., Klotz, T., Brandt, A. S., Roth, S. & Sommer, F., 2008, In: BJU INT. 101, 9, p. 1129-1134 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population.

    Walz, J., Nazareno, S., Hutterer, G. C., Perrotte, P., Gallina, A., Bénard, F., Valiquette, L., McCormack, M., Graefen, M., Montorsi, F. & Karakiewicz, P. I., 2008, In: J ENDOUROL. 22, 2, p. 369-376 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma.

    Bolenz, C., Fernández, M. I., Trojan, L., Herrmann, E., Becker, A., Weiss, C., Alken, P., Ströbel, P. & Michel, M. S., 2008, In: UROLOGY. 72, 2, p. 364-369 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Marked gene transcript level alterations occur early during radical prostatectomy.

    Schlomm, T., Näkel, E., Lübke, A., Buness, A., Chun, F., Steuber, T., Graefen, M., Simon, R., Sauter, G., Poustka, A., Huland, H., Erbersdobler, A., Sültmann, H. & Hellwinkel, O., 2008, In: EUR UROL. 53, 2, p. 333-344 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Methylation of the TPEF- and PAX6-promoters is increased in early bladder cancer and in normal mucosa adjacent to pTa tumours.

    Hellwinkel, O., Kedia, M., Isbarn, H., Budäus, L. & Friedrich, M., 2008, In: BJU INT. 101, 6, p. 753-757 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.

    Schwarzenbach, H., Chun, F., Müller, I., Seidel, C., Urban, K., Erbersdobler, A., Huland, H., Pantel, K. & Friedrich, M., 2008, In: BJU INT. 102, 2, p. 253-258 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Molecular cancer phenotype in normal prostate tissue.

    Schlomm, T., Hellwinkel, O., Buness, A., Ruschhaupt, M., Lübke, A., Chun, F., Simon, R., Budäus, L., Erbersdobler, A., Graefen, M., Huland, H., Poustka, A. & Sültmann, H., 2008, In: EUR UROL.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 men.

    Gallina, A., Nazareno, S., Montorsi, F., Capitanio, U., Jeldres, C., Saad, F., Graefen, M., Shariat, S. F., Widmer, H., Arjane, P., Péloquin, F., Perrotte, P. & Karakiewicz, P. I., 2008, In: INT J CANCER. 123, 3, p. 647-652 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Penile implantation in Europe: successes and complications with 253 implants in Italy and Germany.

    Natali, A., Olianas, R. & Fisch, M., 2008, In: J SEX MED. 5, 6, p. 1503-1512 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.

    Walz, J., Haese, A., Scattoni, V., Steuber, T., Chun, F., Briganti, A., Montorsi, F., Graefen, M., Huland, H. & Karakiewicz, P. I., 2008, In: CANCER-AM CANCER SOC. 113, 10, p. 2695-2703 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.

    Jeldres, C., Suardi, N., Walz, J., Saad, F., Hutterer, G. C., Bhojani, N., Shariat, S. F., Perrotte, P., Graefen, M., Montorsi, F. & Karakiewicz, P. I., 2008, In: EUR UROL. 54, 1, p. 107-116 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Positive Surgical Margins in Radical Prostatectomy: Outlining the Problem and Its Long-Term Consequences.

    Yossepowitch, O., Bjartell, A., Eastham, J. A., Graefen, M., Guillonneau, B. D., Karakiewicz, P. I., Montironi, R. & Montorsi, F., 2008, In: EUR UROL.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer.

    Fischer, N., Hellwinkel, O., Schulz, C., Chun, F., Huland, H., Aepfelbacher, M. & Schlomm, T., 2008, In: J CLIN VIROL. 43, 3, p. 277-283 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Prostate cancer diagnosis: importance of individualized risk stratification models over PSA alone.

    Chun, F., Karakiewicz, P. I. & Briganti, A., 2008, In: EUR UROL. 54, 2, p. 241-242 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Sequential use of the tyrosine kinase inhibitors sorafenib and sunitinib in metastatic renal cell carcinoma: a retrospective outcome analysis.

    Eichelberg, C., Heuer, R., Chun, F., Hinrichs, K., Zacharias, M., Huland, H. & Heinzer, H., 2008, In: EUR UROL. 54, 6, p. 1373-1378 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Serum markers for prostate cancer: a rational approach to the literature.

    Steuber, T., O'Brien, M. F. & Lilja, H., 2008, In: EUR UROL. 54, 1, p. 31-40 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Sorafenib for older patients with renal cell carcinoma: subset analysis from a randomized trial.

    Eisen, T., Oudard, S., Szczylik, C., Gravis, G., Heinzer, H., Middleton, R., Cihon, F., Anderson, S., Shah, S., Bukowski, R. & Escudier, B., 2008, In: JNCI-J NATL CANCER I. 100, 20, p. 1454-1463 20.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer.

    Karakiewicz, P. I., Bhojani, N., Neugut, A., Shariat, S. F., Jeldres, C., Graefen, M., Perrotte, P., Peloquin, F. & Kattan, M. W., 2008, In: J SEX MED. 5, 4, p. 919-927 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive cases.

    Walz, J., Montorsi, F., Jeldres, C., Nazareno, S., Shariat, S. F., Perrotte, P., Arjane, P., Graefen, M., Pharand, D. & Karakiewicz, P. I., 2008, In: BJU INT. 101, 7, p. 826-832 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma.

    Hutterer, G. C., Karakiewicz, P. I., Zippe, C., Lüdecke, G., Boman, H., Sanchez-Carbayo, M., Casella, R., Mian, C., Friedrich, M., Eissa, S., Akaza, H., Serretta, V., Hedelin, H., Rupesh, R., Miyanaga, N., Sagalowsky, A. I., Perrotte, P., Lotan, Y., Marberger, M. J. & Shariat, S. F., 2008, In: BJU INT. 101, 5, p. 561-565 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.

    Jeldres, C., Suardi, N., Walz, J., Hutterer, G. C., Ahyai, S., Lattouf, J-B., Haese, A., Graefen, M., Erbersdobler, A., Heinzer, H., Huland, H. & Karakiewicz, P. I., 2008, In: EUR UROL. 54, 6, p. 1306-1313 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Words of wisdom. Re: Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911.

    Graefen, M., 2008, In: EUR UROL. 53, 3, p. 664-665 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. 2007

  26. Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancer

    Rades, D., Schwarz, R., Todorovic, M., Thurmann, H., Graefen, M., Walz, J., Schild, S. E., Dunst, J. & Alberti, W., 07.2007, In: STRAHLENTHER ONKOL. 183, 7, p. 398-402 5 p., 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer.

    Walz, J., Gallina, A., Hutterer, G., Perrotte, P., Shariat, S. F., Graefen, M., McCormack, M., Bénard, F., Valiquette, L., Saad, F. & Karakiewicz, P. I., 2007, In: INT J RADIAT ONCOL. 69, 1, p. 88-94 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.

    Chun, F., Karakiewicz, P. I., Briganti, A., Walz, J., Kattan, M. W., Huland, H. & Graefen, M., 2007, In: BJU INT. 99, 4, p. 794-800 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer.

    Briganti, A., Chun, F., Salonia, A., Zanni, G., Gallina, A., Dehò, F., Suardi, N., Pozzo, D., Filippo, L., Valiquette, L., Rigatti, P., Montorsi, F. & Karakiewicz, P. I., 2007, In: EUR UROL. 51, 1, p. 112-120 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.

    Walz, J., Gallina, A., Saad, F., Montorsi, F., Perrotte, P., Shariat, S. F., Jeldres, C., Graefen, M., Bénard, F., McCormack, M., Valiquette, L. & Karakiewicz, P. I., 2007, In: J CLIN ONCOL. 25, 24, p. 3576-3581 24.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men.

    Stephan, C., Xu, C., Cammann, H., Graefen, M., Haese, A., Huland, H., Semjonow, A., Diamandis, E. P., Remzi, M., Djavan, B., Wildhagen, M. F., Blijenberg, B. G., Finne, P., Stenman, U-H., Jung, K. & Meyer, H-A., 2007, In: WORLD J UROL. 25, 1, p. 95-103 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Basic principles of anatomy for optimal surgical treatment of prostate cancer.

    Walz, J., Graefen, M. & Huland, H., 2007, In: WORLD J UROL. 25, 1, p. 31-38 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.

    Chun, F., Briganti, A., Graefen, M., Erbersdobler, A., Walz, J., Schlomm, T., Meschke, M., Haese, A., Valiquette, L., Huland, H. & Karakiewicz, P. I., 2007, In: EUR J CANCER. 43, 2, p. 375-382 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.

    Hutterer, G., Perrotte, P., Gallina, A., Walz, J., Jeldres, C., Traumann, M., Suardi, N., Saad, F., Bénard, F., Valiquette, L., McCormack, M., Graefen, M., Montorsi, F. & Karakiewicz, P. I., 2007, In: EUR J CANCER. 43, 7, p. 1180-1187 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Circulating biomarkers for prostate cancer.

    Steuber, T., Helo, P. & Lilja, H., 2007, In: WORLD J UROL. 25, 2, p. 111-119 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.

    Schlomm, T., Kirstein, P., Iwers, L., Daniel, B., Steuber, T., Walz, J., Chun, F., Haese, A., Köllermann, J., Graefen, M., Huland, H., Sauter, G., Simon, R. & Erbersdobler, A., 2007, In: CLIN CANCER RES. 13(22 Pt 1), p. 6579-6584

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.

    Walz, J., Gallina, A., Perrotte, P., Jeldres, C., Trinh, Q-D., Hutterer, G. C., Traumann, M., Ramirez, A., Shariat, S. F., McCormack, M., Perreault, J-P., Bénard, F., Valiquette, L., Saad, F. & Karakiewicz, P. I., 2007, In: BJU INT. 100, 6, p. 1254-1258 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Colon pouch (Mainz III) for continent urinary diversion.

    Stolzenburg, J-U., Schwalenberg, T., Liatsikos, E. N., Sakelaropoulos, G., Rödder, K., Hohenfellner, R. & Fisch, M., 2007, In: BJU INT. 99, 6, p. 1473-1477 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.

    Steuber, T., Vickers, A. J., Serio, A. M., Vaisanen, V., Haese, A., Pettersson, K., Eastham, J. A., Scardino, P. T., Huland, H. & Lilja, H., 2007, In: CLIN CHEM. 53, 2, p. 233-240 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy.

    Briganti, A., Chun, F., Salonia, A., Gallina, A., Zanni, G., Scattoni, V., Valiquette, L., Rigatti, P., Montorsi, F. & Karakiewicz, P. I., 2007, In: UROLOGY. 69, 1, p. 147-151 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer.

    Schwarzenbach, H., Chun, F., Lange, I., Carpenter, S., Gottberg, M., Erbersdobler, A., Friedrich, M., Huland, H. & Pantel, K., 2007, In: INT J CANCER. 120, 7, p. 1465-1471 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Development and external validation of an extended 10-core biopsy nomogram.

    Chun, F., Briganti, A., Graefen, M., Montorsi, F., Porter, C., Scattoni, V., Gallina, A., Walz, J., Haese, A., Steuber, T., Erbersdobler, A., Schlomm, T., Ahyai, S., Eichelberg, E., Valiquette, L., Heinzer, H., Rigatti, P., Huland, H. & Karakiewicz, P. I., 2007, In: EUR UROL. 52, 2, p. 436-444 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Development and external validation of an extended repeat biopsy nomogram.

    Chun, F., Briganti, A., Graefen, M., Porter, C., Montorsi, F., Haese, A., Scattoni, V., Borden, L., Steuber, T., Salonia, A., Schlomm, T., Latchemsetty, K., Walz, J., Kim, J., Eichelberg, C., Eichelberg, E., Ahyai, S., Erbersdobler, A., Valiquette, L., Heinzer, H., Rigatti, P., Huland, H. & Karakiewicz, P. I., 2007, In: J UROLOGY. 177, 2, p. 510-515 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.

    Gallina, A., Chun, F., Briganti, A., Shariat, S. F., Montorsi, F., Salonia, A., Erbersdobler, A., Rigatti, P., Valiquette, L., Huland, H., Graefen, M. & Karakiewicz, P. I., 2007, In: EUR UROL. 52, 1, p. 98-105 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of origin.

    Briganti, A., Shariat, S. F., Chun, F., Hutterer, G. C., Roehrborn, C. G., Gallina, A., Rigatti, P., Valiquette, L., Montorsi, F. & Karakiewicz, P. I., 2007, In: BJU INT. 100, 3, p. 528-532 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer.

    Chun, F., Hutterer, G. C., Perrotte, P., Gallina, A., Valiquette, L., Benard, F., McCormack, M., Briganti, A., Ionescu, C., Jeldres, C., Guay, J-P., Saad, F. & Karakiewicz, P. I., 2007, In: BJU INT. 100, 1, p. 37-41 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. [DNA methylation on urinalysis and as a prognostic marker in urothelial cancer of the bladder]

    Friedrich, M., Toma, M. I., Chun, J. K. H. F., Steuber, T., Budäus, L., Isbarn, H. & Huland, H., 2007, In: UROLOGE. 46, 7, p. 761-768 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Do bladder cancer patients with metastatic spinal cord compression benefit from radiotherapy alone?

    Rades, D., Walz, J., Schild, S. E., Veninga, T. & Dunst, J., 2007, In: UROLOGY. 69, 6, p. 1081-1085 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy.

    Gallina, A., Briganti, A., Chun, F., Walz, J., Hutterer, G. C., Erbersdobler, A., Eichelberg, C., Schlomm, T., Ahyai, S., Perrotte, P., Saad, F., Montorsi, F., Huland, H., Graefen, M. & Karakiewicz, P. I., 2007, In: BJU INT. 100, 6, p. 1249-1253 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Ejaculatory disorders may affect screening for prostate cancer.

    Walz, J., Perrotte, P., Gallina, A., Bénard, F., Valiquette, L., McCormack, M., Montorsi, F. & Karakiewicz, P. I., 2007, In: J UROLOGY. 178, 1, p. 232-238 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. External validation of a nomogram for prediction of side-specific extracapsular extension at robotic radical prostatectomy.

    Zorn, K. C., Gallina, A., Hutterer, G. C., Walz, J., Shalhav, A. L., Zagaja, G. P., Valiquette, L., Gofrit, O. N., Orvieto, M. A., Taxy, J. B. & Karakiewicz, P. I., 2007, In: J ENDOUROL. 21, 11, p. 1345-1351 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.

    Steuber, T., Vickers, A., Haese, A., Kattan, M. W., Eastham, J. A., Scardino, P. T., Huland, H. & Lilja, H., 2007, In: INT J CANCER. 120, 7, p. 1499-1504 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1...30 31 32 33 34 35 36 37 38 Next